penicillamine has been researched along with molybdenum in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (11.11) | 18.7374 |
| 1990's | 7 (19.44) | 18.2507 |
| 2000's | 14 (38.89) | 29.6817 |
| 2010's | 10 (27.78) | 24.3611 |
| 2020's | 1 (2.78) | 2.80 |
| Authors | Studies |
|---|---|
| Kikuchi, T; Sugiura, Y; Tanaka, H | 1 |
| Cramarossa, L; D'Angelo, D; D'Ascanio, I; Ferri, GB; Piane, E | 1 |
| Lamand, M; Mason, J; McQuaid, A | 1 |
| Mason, J; McQuaid, A | 1 |
| Danks, DM | 1 |
| Brewer, GJ; Yuzbasiyan-Gurkan, V | 1 |
| Halstead, BW; Williams, DR | 1 |
| Bianco, P; Donato Bianco, V; Gallo, N; Luisi, G | 1 |
| Scheinberg, IH; Sternlieb, I | 1 |
| Brewer, GJ | 5 |
| Schilsky, ML | 2 |
| Vanchieri, C | 1 |
| Bronstein, JM; Subramanian, I; Vanek, ZF | 1 |
| Pérez-Aguilar, F | 1 |
| Brechbiel, M; Camphausen, K; Sproull, M | 1 |
| El-Youssef, M | 1 |
| Szalay, F | 1 |
| Hayashi, H; Suzuki, R; Wakusawa, S | 1 |
| Medici, V; Rossaro, L; Sturniolo, GC | 1 |
| Angelos, J; Cornish, J; George, L; Miller, G; Puschner, B | 1 |
| Purchase, R | 1 |
| Brůha, R; Mareček, Z | 1 |
| Stremmel, W; Weiss, KH | 1 |
| Chen, DB; Feng, L; Hou, HM; Li, XH; Liu, JX; Wei, LT; Wu, C; Zhang, JW | 1 |
| Chen, C; Li, WJ; Wang, XP; Yang, RM; You, ZF | 1 |
| Alhonen, L; Hyvönen, MT; Keinänen, TA; Khomutov, AR; Khomutov, M; Pasanen, M; Peräniemi, S; Ucal, S; Vepsäläinen, J; Weisell, J | 1 |
| Członkowska, A; Litwin, T | 1 |
| Cui, H; Geraghty, D; Guven, N; Liu, JJ; McKeage, MJ; Nott, LM; Zhang, AJ | 1 |
| Pfister, ED | 1 |
| Appenzeller-Herzog, C; Ewald, H; Heeres, MLS; Houwen, RHJ; Mathes, T; Weiss, KH | 1 |
| Adamski, J; Borchard, S; Coles, AH; Eberhagen, C; Einer, C; Klingenspor, M; Lichtmannegger, J; Michalke, B; Müller, SM; Plitz, T; Popowicz, GM; Raschke, S; Rieder, T; Sandahl, TD; Schwerdtle, T; Vendelbo, MH; Viana, R; Weber, E; Wieser, A; Zak, KM; Zischka, H | 1 |
25 review(s) available for penicillamine and molybdenum
| Article | Year |
|---|---|
[Wilson's disease].
Topics: Acetates; Acetic Acid; Adult; Diagnosis, Differential; Diet; Female; Hepatolenticular Degeneration; Humans; Male; Molybdenum; Penicillamine; Pyridoxine; Sulfates; Trientine; Zinc; Zinc Sulfate | 1992 |
Copper and liver disease.
Topics: Adult; Chelating Agents; Child; Cholestasis; Copper; Hepatolenticular Degeneration; Humans; Infant; Infant, Newborn; Liver Diseases; Molybdenum; Penicillamine; Zinc | 1991 |
Wilson's disease: an update, with emphasis on new approaches to treatment.
Topics: Copper; Female; Hepatolenticular Degeneration; Humans; Molybdenum; Penicillamine; Pregnancy; Trientine; Zinc | 1989 |
Chelating agents in medicine.
Topics: Aluminum; Cadmium; Chelating Agents; Chromium; Copper; Deferoxamine; Dimercaprol; Edetic Acid; Environmental Pollutants; Humans; Iron; Mercury; Metals; Molybdenum; Penicillamine; Plutonium; Unithiol | 1982 |
Practical recommendations and new therapies for Wilson's disease.
Topics: Chelating Agents; Copper; Female; Hepatolenticular Degeneration; Humans; Liver; Metallothionein; Molybdenum; Penicillamine; Pregnancy; Trientine; Zinc | 1995 |
Wilson disease: genetic basis of copper toxicity and natural history.
Topics: Adenosine Triphosphatases; Carrier Proteins; Cation Transport Proteins; Chelating Agents; Chelation Therapy; Chromosome Mapping; Copper; Copper-Transporting ATPases; Environment; Genetic Therapy; Genome, Human; Hepatitis; Hepatolenticular Degeneration; Humans; Liver Transplantation; Molybdenum; Mutation; Penicillamine; Risk Factors; Trientine; Zinc | 1996 |
Treatment of Wilson's disease: what are the relative roles of penicillamine, trientine, and zinc supplementation?
Topics: Adenosine Triphosphatases; Chelating Agents; Drug Therapy, Combination; Female; Hepatolenticular Degeneration; Humans; Molybdenum; Penicillamine; Pregnancy; Trientine; Zinc | 2001 |
Diagnosis and treatment of Wilson's disease.
Topics: Chelating Agents; Copper; Dimercaprol; Enzyme Inhibitors; Female; Hepatolenticular Degeneration; Humans; Liver Transplantation; Male; Molybdenum; Penicillamine; Trientine; Zinc | 2002 |
[Wilson's disease: physiopathological, clinical and therapeutic considerations].
Topics: Adenosine Triphosphatases; Adolescent; Adult; Basal Ganglia Diseases; Brain; Cation Transport Proteins; Ceruloplasmin; Chelating Agents; Chelation Therapy; Copper; Copper-Transporting ATPases; Descemet Membrane; Female; Genes, Recessive; Hepatitis, Chronic; Hepatolenticular Degeneration; Humans; Liver Transplantation; Male; Mental Disorders; Middle Aged; Molybdenum; Penicillamine; Pregnancy; Pregnancy Complications; Prognosis; Recombinant Fusion Proteins; Trientine; Zinc | 2003 |
Antiangiogenic therapy through copper chelation.
Topics: Angiogenesis Inhibitors; Animals; Chelating Agents; Chelation Therapy; Copper; Corneal Neovascularization; Cyclohexylamines; Hepatolenticular Degeneration; Humans; Molybdenum; Neoplasms; Neovascularization, Pathologic; Penicillamine; Pyridines; Rabbits; Trientine | 2003 |
Wilson disease.
Topics: Adenosine Triphosphatases; Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Liver Transplantation; Molybdenum; Penicillamine; Trientine; Zinc | 2003 |
[Wilson disease in 2003].
Topics: Adenosine Triphosphatases; Cation Transport Proteins; Chelating Agents; Copper; Copper-Transporting ATPases; Diagnosis, Differential; Family Planning Services; Genetic Counseling; Genotype; Hepatolenticular Degeneration; Humans; Molybdenum; Penicillamine; Phenotype; Trientine; Zinc Acetate; Zinc Sulfate | 2003 |
[Wilson's disease and its pharmacological treatment].
Topics: Adenosine Triphosphatases; Biomarkers; Cation Transport Proteins; Ceruloplasmin; Chelating Agents; Chelation Therapy; Copper; Copper-Transporting ATPases; Female; Hepatolenticular Degeneration; Humans; Iron; Male; Molecular Diagnostic Techniques; Molybdenum; Mutation; Penicillamine; Pregnancy; Pregnancy Outcome; Zinc Acetate | 2004 |
Neurologically presenting Wilson's disease: epidemiology, pathophysiology and treatment.
Topics: Behavior; Chelating Agents; Enzyme Inhibitors; Hepatolenticular Degeneration; Humans; Molybdenum; Nervous System Diseases; Penicillamine; Trientine; Zinc | 2005 |
Anticopper therapy against cancer and diseases of inflammation and fibrosis.
Topics: Animals; Copper; Fibrosis; Humans; Inflammation; Molybdenum; Neoplasms; Neovascularization, Pathologic; Penicillamine; Trientine | 2005 |
Novel therapeutic approaches to the treatment of Wilson's disease.
Topics: Chelating Agents; Child; Child, Preschool; Clinical Trials as Topic; Copper; Female; Hepatolenticular Degeneration; Humans; Molybdenum; Penicillamine; Pregnancy; Pregnancy Complications; Zinc | 2006 |
Wilson disease--a practical approach to diagnosis, treatment and follow-up.
Topics: Ceruloplasmin; Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Liver Transplantation; Molybdenum; Mutation; Penicillamine; Trace Elements; Treatment Outcome; Trientine; Zinc | 2007 |
The risks of free copper in the body and the development of useful anticopper drugs.
Topics: Alzheimer Disease; Angiogenesis Inhibitors; Autoimmunity; Copper; Fibrosis; Hepatolenticular Degeneration; Humans; Inflammation; Molybdenum; Neurodegenerative Diseases; Penicillamine; Trientine | 2008 |
The treatment of Wilson's disease, a rare genetic disorder of copper metabolism.
Topics: Brain; Chelating Agents; Copper; Cornea; Dimercaprol; Drug Discovery; Hepatolenticular Degeneration; History, 20th Century; Humans; Liver; Molybdenum; Penicillamine; Rare Diseases; Trientine; Zinc Sulfate | 2013 |
[Wilsons disease].
Topics: Adenosine Triphosphatases; Adult; Cation Transport Proteins; Chelating Agents; Copper; Copper-Transporting ATPases; Czech Republic; Female; Hepatolenticular Degeneration; Humans; Liver Cirrhosis; Liver Transplantation; Male; Molybdenum; Mutation; Penicillamine; Trientine; Zinc | 2013 |
Clinical considerations for an effective medical therapy in Wilson's disease.
Topics: Ceruloplasmin; Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Molybdenum; Penicillamine; Trientine; Zinc | 2014 |
Current Drug Managements of Wilson's Disease: From West to East.
Topics: Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Medicine, Chinese Traditional; Molybdenum; Penicillamine; Succimer; Treatment Outcome; Trientine; Zinc | 2016 |
Wilson disease - currently used anticopper therapy.
Topics: Chelating Agents; Copper; Enzyme Inhibitors; Hepatolenticular Degeneration; Humans; Molybdenum; Penicillamine; Prospective Studies; Trientine | 2017 |
[Wilson's disease : What has been confirmed in diagnostic and therapy?]
Topics: Chelating Agents; Chromosome Aberrations; Copper; Diet Therapy; Genes, Recessive; Hepatolenticular Degeneration; Humans; Liver Transplantation; Molybdenum; Penicillamine; Phenotype; Zinc | 2017 |
Comparative effectiveness of common therapies for Wilson disease: A systematic review and meta-analysis of controlled studies.
Topics: Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Liver; Molybdenum; Penicillamine; Randomized Controlled Trials as Topic; Trientine; Zinc | 2019 |
11 other study(ies) available for penicillamine and molybdenum
| Article | Year |
|---|---|
Spectroscopic and catalytic properties of penicillamine-molybdenum complexes.
Topics: Catalysis; Chemical Phenomena; Chemistry; Electron Spin Resonance Spectroscopy; Light; Molybdenum; Oxidation-Reduction; Penicillamine; Spectrophotometry, Infrared; Spectrum Analysis | 1977 |
The interactions of penicillamine with copper in vivo and the effect on hepatic metallothionein levels and copper/zinc distribution: the implications for Wilson's disease and arthritis therapy.
Topics: Animals; Arthritis; Copper; Cytosol; Hepatolenticular Degeneration; Humans; Injections, Intramuscular; Liver; Male; Metallothionein; Methionine; Molybdenum; Organometallic Compounds; Penicillamine; Rats; Rats, Inbred Strains; Reference Values; Zinc | 1992 |
A comparison of the effects of penicillamine, trientine, and trithiomolybdate on [35S]-labeled metallothionein in vitro; implications for Wilson's disease therapy.
Topics: Animals; Copper; Cytosol; Hepatolenticular Degeneration; Liver; Male; Metallothionein; Molybdenum; Penicillamine; Rats; Rats, Inbred Strains; Sulfur Radioisotopes; Trientine | 1991 |
[Spectrophotometric determination of penicillamine with phosphomolybdic acid].
Topics: Molybdenum; Penicillamine; Phosphoric Acids; Spectrophotometry | 1980 |
Treatment of the neurologic manifestations of Wilson's disease.
Topics: Dimercaprol; Hepatolenticular Degeneration; Humans; Molybdenum; Nervous System Diseases; Penicillamine | 1995 |
Cutting copper curbs angiogenesis, studies show.
Topics: Angiogenesis Inhibitors; Brain Neoplasms; Chelating Agents; Clinical Trials as Topic; Combined Modality Therapy; Copper; Glioblastoma; Humans; Molybdenum; Neoplasms; Neovascularization, Pathologic; Penicillamine | 2000 |
Copper toxicosis in a dairy goat herd.
Topics: Animal Feed; Animals; Antidotes; Copper; Female; Goat Diseases; Goats; Liver; Molybdenum; Penicillamine; Poisoning; Thiosulfates; Trace Elements; Vitamin E | 2007 |
Effects of tetrathiomolybdate and penicillamine on brain hydroxyl radical and free copper levels: a microdialysis study in vivo.
Topics: Animals; Brain; Chelating Agents; Copper; Corpus Striatum; Disease Models, Animal; Hepatolenticular Degeneration; Hydroxyl Radical; Mice, Inbred C57BL; Mice, Mutant Strains; Microdialysis; Molybdenum; Penicillamine | 2015 |
Triethylenetetramine modulates polyamine and energy metabolism and inhibits cancer cell proliferation.
Topics: Amine Oxidase (Copper-Containing); Cell Line, Tumor; Cell Proliferation; Eflornithine; Energy Metabolism; Female; Humans; Male; MCF-7 Cells; Molybdenum; Penicillamine; Polyamines; Putrescine; Reactive Oxygen Species; Spermine; Trientine | 2016 |
Copper transporter 1 in human colorectal cancer cell lines: Effects of endogenous and modified expression on oxaliplatin cytotoxicity.
Topics: Antineoplastic Agents; Cation Transport Proteins; Cell Line, Tumor; Chelating Agents; Copper; Copper Transporter 1; Copper-Transporting ATPases; Drug Synergism; Humans; Molybdenum; Organoplatinum Compounds; Oxaliplatin; Penicillamine; Phenanthrolines; Up-Regulation | 2017 |
Bis-choline tetrathiomolybdate prevents copper-induced blood-brain barrier damage.
Topics: Animals; Biological Transport; Biomarkers; Blood-Brain Barrier; Brain; Cell Survival; Chelating Agents; Copper; Endothelial Cells; Humans; Mice, Transgenic; Mitochondria; Models, Molecular; Molybdenum; Penicillamine; Positron-Emission Tomography; Protein Binding; Rats; Serum Albumin; Structure-Activity Relationship | 2022 |